Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin 40 mg versus placebo for carpal tunnel syndrome
IRCT20231020059773N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in carpal tunnel syndrome (CTS) comparing Rosuvastatin 40 mg with Placebo (2 arms). Primary endpoints: Median nerve amplitude, Median nerve latency and 7 more. Started Jan 2024; status: completed.
02
Drugs
rosuvastatin
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on IRCT20231020059773N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231020059773N1.